论文部分内容阅读
Glucocorticoids are critical components of combination chemotherapy regimens in pediatric acute lymphoblastic leukemia (ALL).However,the emergence of resistance remains a significant barrier to cure,and clinically relevant mechanisms of resistance are poorly understood.